🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsMASH / Liver DiseaseSurvodutide SYNCHRONIZE Phase 3 — November 2025 Page 8

Survodutide SYNCHRONIZE Phase 3 — November 2025

ZaraB_AL Thu, Sep 12, 2024 at 4:18 AM 56 replies 2,243 viewsPage 8 of 12
MariaRD
Member
823
4,567
Jun 2024
New Mexico
Jan 15, 2025 at 12:58 AM#36
stefan_berlin said:
If you are going to change something, change one thing and give it long enough to express itself.

Filing a mild objection. Mild because I might be wrong; an objection because nobody has addressed the case that does not fit. I would resist the confidence. Half of what this board was certain about two years ago has since been quietly dropped, and nobody went back to correct the threads.

21 19Dr.NutriCornell, pam_stl, wei_SG and 18 others
Reply Quote Save Share Report
wendy_avl
Member
245
1,123
Oct 2024
Asheville, NC
Jan 21, 2025 at 11:49 PM#37
stefan_berlin said:
If you are going to change something, change one thing and give it long enough to express itself.

Fair, and it stops being fair at the extremes. The middle of the range is well understood; the ends are where the honest answer is that nobody knows.

22 20DoseLogDan, SleepFixSam, PurityPaulOR and 19 others
Reply Quote Save Share Report
carlos_SATX
Member
245
1,123
Oct 2024
San Antonio, TX
Jan 28, 2025 at 10:36 PM#38
stefan_berlin said:
If you are going to change something, change one thing and give it long enough to express itself.

Thank you — that is the clearest version of this I have read, and I have read a lot of them. Taking it to my next appointment.

Last edited: Jan 29, 2025 at 12:36 AM
23 21Dr.BariatricHTX, LindaRN_retired, tommy_boulder and 20 others
Reply Quote Save Share Report

Sigma-Aldrich — Research-Grade Standards

Certified reference materials, analytical reagents, and research-grade standards for peptide verification. Trusted by laboratories worldwide.

Shop Reference Standards
PharmHunterJen
Member
567
2,345
Jul 2024
Illinois
Feb 4, 2025 at 9:19 PM#39

Clinical perspective, offered as context rather than as advice. Start from the measurement rather than the conclusion. Almost every disagreement here turns out to be two people measuring different things and comparing the numbers anyway.

24 22Dr.PainCLE, mike_mealprep, NicoleRaleigh and 21 others
Reply Quote Save Share Report
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Feb 11, 2025 at 7:58 PM#40
PharmHunterJen said:
Start from the measurement rather than the conclusion.

Second this. I had assumed I was the exception until I read this.

46 19hyun_seoul, jim_asheville, matt_MKE and 43 others
Reply Quote Save Share Report
167891012

Similar Threads

Survodutide MASH Phase 2b — histological improvement data9 replies
Semaglutide and MASH — liver fat reduction quantification13 replies
Non-invasive MASH biomarkers — FibroScan, ELF, FIB-4 on GLP-110 replies
ALT normalization rates on GLP-1 — pooled trial data20 replies
GLP-1 hepatoprotection — direct vs indirect mechanisms16 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register